This post is from a suggested group
The Global Peripheral Artery Disease Market: Addressing the Growing Burden of Atherosclerosis, Driving Demand for Minimally Invasive Endovascular Interventions, and Advancements in Drug-Coated Balloons
The Peripheral Artery Disease (PAD) Market is experiencing significant expansion, primarily driven by the escalating prevalence of cardiovascular risk factors globally, most notably the rising rates of diabetes, hypertension, and obesity, which accelerate the progression of atherosclerosis in the non-coronary arteries. The primary market catalyst is the increasing awareness and diagnosis of PAD, leading to a surge in demand for both surgical and endovascular treatments to restore blood flow and prevent limb amputation, particularly in the critical limb ischemia (CLI) population. The discussion must emphasize the transformative shift from traditional open surgical bypass procedures to minimally invasive endovascular interventions (EVIs), including percutaneous transluminal angioplasty (PTA) and stenting, which offer shorter hospital stays, quicker recovery times, and reduced procedural morbidity. Continuous technological innovation, such as the development…